Sanderling Ventures financial update

GlaxoSmithKline plc (LSE:GSK; NYSE:GSK, London, U.K.) said it will contribute $50 million to Sanderling Ventures' new $250 million Sanderling VII fund. The pharma did not provide details on the timin...